Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Beyond COVID-19: Industry Insiders Offer 10 Strategies For Medtech Recovery

Executive Summary

Medtech insiders offer 10 strategies for medtech companies to rethink their businesses right now.

You may also be interested in...



Philips Sales Slide In Q2 But COVID-19 Drives Growth In Connected Care

Philips reported $4.97bn in sales for the second quarter of 2020, a 6% decline compared to the second quarter of last year. While the pandemic slowed down demand across the business, Philips connected care business increased by 14% due to demand for respiratory devices.

Exec Chat: Boston Scientific’s Angelo De Rosa Forsees Digital Transformation In The COVID-19 Era

Angelo De Rosa, VP of Boston Scientific's cardiac rhythm management business in Europe, the Middle East and Africa, talked to Medtech Insight about the opportunities to accelerate digital transformation in health care during the COVID-19 crisis.

VC Deals Analysis, H1 2020: Medtech Funding Stays Apace, Cardiovascular Is King

A steady flow of venture capital into the medical device industry continued in the first half of 2020 despite the pandemic. Medtech start-ups raised more than $1.5bn with Medtech Insight tracking over 40 financial deals of $1m-and-over.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

MT142228

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel